Mineralys Loss Widens as Blood Pressure Drug Nears FDA Decision
Image supplied with the source report: Mychesco.

RADNOR, PA — Mineralys Therapeutics Inc. (Nasdaq: MLYS) reported a widening third-quarter loss as spending on commercial preparations for its experimental hypertension drug lorundrostat accelerated ahead of a…

RADNOR, PA — Mineralys Therapeutics Inc. (Nasdaq: MLYS) reported a widening third-quarter loss as spending on commercial preparations for its experimental hypertension drug lorundrostat accelerated ahead of a Dec. 22, …

Source disclosure

This is a source-linked briefing. Read the original report from Mychesco .

World News regional mineralys therapeutics delaware county business news